ArticleFrontiers in oncology2025

Significant response to toripalimab plus axitinib for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report and literature review.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.